In the PBMCs of AD patients, on the other hand, SA-β-Gal, Go/G1 and IL-6 and IL-8 mRNA expressions—which were increased in aMCI PBMCs—had levels comparable to controls. This evidence concerns the gene IL6 and Alzheimer disease.